| Literature DB >> 28878932 |
Ingrid Sørdal Følling1,2,3, Bård Kulseng3,4, Kristian Midthjell5, Vegar Rangul1,5, Anne-S Helvik2,6,7.
Abstract
OBJECTIVE: Prevention of type 2 diabetes mellitus is possible through lifestyle programs, but the effect depends on the program's content, resources, and setting. Lifestyle programs are often confronted with high rates of non-participation and attrition. This study invited individuals at high risk for type 2 diabetes to a lifestyle program in the Norwegian primary healthcare setting. The aims were to investigate possible differences in characteristics between participants and non-participants and to study the effect of the lifestyle program at 24-month follow-up for participants. RESEARCH DESIGN AND METHODS: Individuals identified at high risk for type 2 diabetes during the third survey of the Nord-Trøndelag Health Study (HUNT3) from two municipalities (n=332) were invited to a lifestyle program (the VEND-RISK Study). A cross-sectional design was used to explore if the participants' characteristics differed from non-participants. A non-randomized, single-arm, pre-post examination was used to examine the effect of the lifestyle program on participants' characteristics at 24-month follow-up.Entities:
Keywords: FINDRISC; lifestyle programme; non-participants; primary health care; type 2 diabetes
Year: 2017 PMID: 28878932 PMCID: PMC5574427 DOI: 10.1136/bmjdrc-2016-000368
Source DB: PubMed Journal: BMJ Open Diabetes Res Care ISSN: 2052-4897
Figure 1The studys overview from the beginning, in which individuals who were identified at high risk for type 2 diabetes at the HUNT3 Study in 2006 to 2008 and who were also located in the two municipalities for the VEND-RISK Study, were invited to participate in the lifestyle program at Healthy Life Centre in 2013.
Characteristics (means (SD)) and comparison between participants and non-participants from the baseline HUNT3 Survey (n=332)
| Participants (n=45) | Non-participants (n=287) | p Value | |
|
|
|
| |
| Age (years) | |||
| Women | 58.5 (9.5) | 60.1 (9.8) | 0.24 |
| Men | 59.5 (5.8) | 59.5 (9.3) | 0.99 |
| FINDRISC score | |||
| Women | 16.4 (1.9) | 16.9 (2.0) | 0.22 |
| Men | 17.2 (1.9) | 16.9 (2.3) | 0.65 |
| Years of education | |||
| Women | 12.6 (3.1) | 10.7 (3.1) | 0.001* |
| Men | 12.7 (3.2) | 11.7 (3.2) | 0.22 |
| Working | |||
| Women | 65.4% | 44.7% | 0.05 |
| Men | 66.7% | 57.6% | 0.47 |
| BMI (kg/m2) | |||
| Women | 30.6 (3.8) | 31.0 (4.4) | 0.65 |
| Men | 31.3 (3.2) | 31.3 (3.3) | 0.98 |
| Weight (kg) | |||
| Women | 83.5 (10.6) | 83.5 (13.5) | 0.99 |
| Men | 100.9 (12.4) | 98.4 (11.7) | 0.39 |
| Waist circumference (cm) | |||
| Women | 101.0 (7.99) | 101.0 (12.4) | 0.90 |
| Men | 109.0 (8.2) | 108.0 (8.4) | 0.59 |
| Triglycerides (mmol/L) | |||
| Women | 1.8 (0.9) | 1.8 (1.0) | 0.77 |
| Men | 2.0 (1.1) | 2.2 (1.2) | 0.47 |
| Total cholesterol (mmol/L) | |||
| Women | 6.0 (1.2) | 5.8 (1.0) | 0.28 |
| Men | 5.4 (1.1) | 5.5 (1.1) | 0.68 |
| HDL cholesterol (mmol/L) | |||
| Women | 1.4 (0.4) | 1.4 (0.4) | 0.91 |
| Men | 1.1 (0.3) | 1.2 (0.3) | 0.37 |
| Serum glucose (mmol/L) | |||
| Women | 5.5 (0.7) | 5.8 (1.3) | 0.27 |
| Men | 5.9 (1.1) | 6.2 (1.8) | 0.57 |
| Sitting time (hours a day) | |||
| Women | 6.2 (3.7) | 5.9 (2.7) | 0.68 |
| Men | 6.2 (3.5) | 6.1 (3.0) | 0.87 |
| Physical activity (hours/week) | |||
| Women | 5.8 (3.4) | 5.4 (4.4) | 0.70 |
| Men | 6.5 (5.4) | 6.6 (5.4) | 0.90 |
| Self-perceived health (Subjective Well-Being) Good | |||
| Women | 65.4% | 57.6% | 0.47 |
| Men | 61.1% | 64.4% | 0.91 |
| Physical or emotional health impacts on social relations the last 14 days | |||
| Women | 19.2% | 40.6% | 0.04 |
| Men | 22.2% | 28.0% | 0.57 |
*Significant p<0.003.
BMI, body mass index; FINDRISC, Finnish Diabetes Risk Score; HDL, high-density lipoprotein.
Participants characteristics at the VEND-RISK Study baseline measurements (meansSD) and participants changes from baseline to the end of lifestyle program (meansSD) and to 24-month follow-up (meansSD).
| Baseline means (SD) | Changes from baseline to end of program | p Value* | Changes from baseline to 24-month follow-up | p Value | |
| Weight (kg) | |||||
| Women | 83.0(12.4) | -1.0(3.9) | 0.22 | -1.4 (5.8) | 0.22 |
| Men | 97.2(11.9) | -0.3(3.4) | 0.68 | - 0.9 (6.3) | 0.53 |
| BMI (kg/m2) | |||||
| Women | 30.3(4.2) | -0.4(1.4) | 0.21 | -0.6 (2.1) | 0.21 |
| Men | 29.9(2.8) | -0.1(1.1) | 0.72 | -0.2(1.9) | 0.59 |
| Waist circumference (cm) | |||||
| Women | 102.4(9.5) | -2.7(3.9) | 0.001* | -4.0(5.4) | 0.001* |
| Men | 107.1(6.1) | -0.5(3.8) | 0.60 | -1.7(6.2) | 0.20 |
| FINDRISC Score | |||||
| Women | 16.8(2.6) | -1.1(2.8) | 0.08 | -1.2(3.2) | 0.09 |
| Men | 16.3(3.8) | +0.5(2.8) | 0.36 | -0.2(2.8) | 0.69 |
| HbA1c (mmol/mol) | |||||
| Women | 5.8(0.3) | -0.2(0.2) | 0.001* | --0.2 (0.02) | 0.001* |
| Men | 6.0(0.6) | -0.2(0.2) | 0.001* | -0.2(0.4) | 0.03** |
| Fasting blood glucose(mg/dL) | |||||
| Women | 5.6(0.7) | -0.2(0.6) | 0.18 | -0.1(0.5) | 0.24 |
| Men | 5.9(1.3) | +0.0(0.6) | 0.44 | +0.3(0.4) | 0.03** |
| Total cholesterol (mg/dL) | |||||
| Women | 5.4(0.9) | +2.0(0.6) | 0.001* | +0.1(0.8) | 0.42 |
| Men | 4.9(1.1) | +1.5(0.5) | 0.001* | -0.2(0.6) | 0.25 |
| HDL cholesterol (mg/dL) | |||||
| Women | 1.8(0.9) | -0.2(0.9) | 0.06 | -0.2(0.9) | 0.86 |
| Men | 1.3(0.3) | 0.0(0.1) | 0.95 | 0.0(0.1) | 0.95 |
| LDL cholesterol (mg/dL) | |||||
| Women | 3.3(1.1) | 0.0(0.4) | 0.81 | +0.2(0.8) | 0.19 |
| Men | 3.1(1.0) | -0.2(0.4) | 0.06 | -0.1(0.6) | 0.68 |
| Triglycerides (mg/dL) | |||||
| Women | 1.2(0.5) | +0.1(0.5) | 0.93 | +0.2(0.4) | 0.06 |
| Men | 1.3(0.7) | -0.1(0.3) | 0.14 | +0.1(0.2) | 0.13 |
| COOP/WONKA Physical activities as hard | |||||
| Women | 23.1% | -0.1(0.4) | 0.13 | +0.1(0.5) | 0.78 |
| Men | 42.1% | -0.1(0.6) | 0.28 | +0.0(0.6) | 0.63 |
| COOP/WONKA Overall health as good | |||||
| Women | 76.9% | +0.1(0.5) | 0.41 | 0.0(0.6) | 0.71 |
| Men | 52.6% | -0.2(0.5) | 0.18 | -0.1(0.5) | 0.10 |
| COOP/WONKA Health impact on social activities | |||||
| Women | 19.2% | 0.0(0.4) | 1.00 | +0.1(0.4) | 0.32 |
| Men | 0.0% | +0.1(0.2) | 0.32 | +0.1(0.2) | 0.32 |
** Significant p<0.05.
*Significant p<0.002.
Wilcoxon test used.
BMI, body mass index; FINDRISC, Finnish Diabetes Risk Score; HDL, high-density lipoprotein.